📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Engineered hyperphosphorylation of the ß2-adrenoceptor prolongs arrestin-3 binding and induces arrestin internalization. (2015)

First Author: Zindel D

Attributed to: Using a Designer Receptor Exclusively Activated by Designer Drug to define the role of short chain fatty acids in metabolic disease and inflammation funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1124/mol.114.095422

PubMed Identifier: 25425623

Publication URI: http://europepmc.org/abstract/MED/25425623

Type: Journal Article/Review

Volume: 87

Parent Publication: Molecular pharmacology

Issue: 2

ISSN: 0026-895X